PLUS1
1,658.20
8.20 (0.50%)
8.20 (0.50%)
Upgrade to Real-Time
Market Closed
Best deals to access real time data! |
|
Real-time Level 1 for London Stock Exchange
Monthly Subscription
for only
$29.56
|
|
London Stock Exchange Level 2
Monthly Subscription
for only
$77.61
|
|
Real-time London Stock Exchange & FTSE
Monthly Subscription
for only
$88.69
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type | ISIN | Company Description |
|---|---|---|---|---|---|
| Glaxosmithkline Plc | GSK | London | Ordinary Share | GB0009252882 | ORD 25P |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 8.20 | 0.5% | 1,658.20 | 1,640.00 | 1,658.80 | 1,644.00 | 1,650.00 | 11:35:04 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 1,654.40 | 1,655.00 | 0.60 | 0.04% | 1 | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 10,930 | 6,880,842 | 1,652.88p | 113,732,398p | - | 1,485.20 - 1,857.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 13:45:01 | O | 75 | 1,647.302p | GBX |
| Industry Sector |
|---|
| PHARMACEUTICALS & BIOTECHNOLOGY |
Glaxosmithkline Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| 82.00Bp | - | - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | -p | 0.00% | - | - |
Glaxosmithkline News
| Date | Time | Source | News Article |
|---|---|---|---|
| 2/21/2020 | 08:00 | UK Regulatory (RNS & others) | GlaxoSmithKline PLC Director/PDMR Shareholding |
| 2/20/2020 | 10:30 | UK Regulatory (RNS & others) | GlaxoSmithKline PLC Director/PDMR Shareholding |
| 2/20/2020 | 09:00 | UK Regulatory (RNS & others) | GlaxoSmithKline PLC Director/PDMR Shareholding |
| 2/20/2020 | 05:29 | Dow Jones News | GlaxoSmithKline Invests $50 Million in Biotech Startup's.. |
| 2/19/2020 | 12:25 | UK Regulatory (RNS & others) | GlaxoSmithKline PLC Director/PDMR Shareholding |
| 2/19/2020 | 11:35 | UK Regulatory (RNS & others) | GlaxoSmithKline PLC Director/PDMR Shareholding |
| 2/19/2020 | 11:28 | UK Regulatory (RNS & others) | GlaxoSmithKline PLC Director/PDMR Shareholding |
Glaxosmithkline Discussion Forums - GSK
| Date | Time | Comments | Title |
|---|---|---|---|
| 10/29/2019 | 09:13 | - | Sci-B-Vac data is in December. That''s the drug |
| 10/25/2019 | 07:29 | - | $VBIV VBI Vaccines will collaborate with GlaxoSmithKline |
| 10/24/2019 | 14:25 | - | $VBIV VBI Vaccines will collaborate with GlaxoSmithKline ( |
| 10/23/2019 | 12:37 | - | $GSK and $VBIV VBI Vaccines teams up with |
| 10/23/2019 | 11:10 | - | Watch this one go up with Tesaro approval. |
| 10/06/2019 | 11:41 | - | Certainly a great LONG term hold. ;) |
| 10/06/2019 | 11:16 | - | YIKES haha nice up tick with a great divvy. |
| 10/06/2019 | 03:40 | - | $41.99 now. :) |
| 12/19/2018 | 04:42 | - | Yep 39 now with 5% divvy I don''t |
| 12/19/2018 | 04:18 | - | GSK, PFE form consumer-health JV: #msg-145552190. |
Historical GSK Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1,682.20 | 1,688.20 | 1,640.00 | 1,665.13 | 8,681,978 | -24.00 | -1.43% |
| 1 Month | 1,823.60 | 1,857.00 | 1,640.00 | 1,722.88 | 10,404,188 | -165.40 | -9.07% |
| 3 Months | 1,754.00 | 1,857.00 | 1,640.00 | 1,761.02 | 9,391,272 | -95.80 | -5.46% |
| 6 Months | 1,663.20 | 1,857.00 | 1,612.40 | 1,728.29 | 8,742,329 | -5.00 | -0.3% |
| 1 Year | 1,551.00 | 1,857.00 | 1,485.20 | 1,659.18 | 8,501,774 | 107.20 | 6.91% |
| 3 Years | 1,636.50 | 1,857.00 | 1,236.40 | 1,546.71 | 9,014,899 | 21.70 | 1.33% |
| 5 Years | 1,527.50 | 1,857.00 | 1,227.50 | 1,518.17 | 9,003,161 | 130.70 | 8.56% |
